174 related articles for article (PubMed ID: 17097651)
1. Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome.
Maliqueo M; Bacallao K; Quezada S; Clementi M; Gabler F; Johnson MC; Vega M
Fertil Steril; 2007 Feb; 87(2):321-8. PubMed ID: 17097651
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome.
Quezada S; Avellaira C; Johnson MC; Gabler F; Fuentes A; Vega M
Fertil Steril; 2006 Apr; 85(4):1017-26. PubMed ID: 16580389
[TBL] [Abstract][Full Text] [Related]
3. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
[TBL] [Abstract][Full Text] [Related]
4. Serum sex hormone-binding globulin levels show too much variability to be used effectively as a screening marker for insulin resistance in women with polycystic ovary syndrome.
Dahan MH; Goldstein J
Fertil Steril; 2006 Oct; 86(4):934-41. PubMed ID: 17027360
[TBL] [Abstract][Full Text] [Related]
5. The conversion of dehydroepiandrosterone into androst-5-ene-3beta,17beta-diol (androstenediol) is increased in endometria from untreated women with polycystic ovarian syndrome.
Plaza F; Gabler F; Romero C; Vantman D; Valladares L; Vega M
Steroids; 2010 Dec; 75(12):810-7. PubMed ID: 20620158
[TBL] [Abstract][Full Text] [Related]
6. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome.
Avellaira C; Villavicencio A; Bacallao K; Gabler F; Wells P; Romero C; Vega M
Hum Reprod; 2006 Dec; 21(12):3116-21. PubMed ID: 17008325
[TBL] [Abstract][Full Text] [Related]
7. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
8. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
9. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
10. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
11. Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS.
Chen MJ; Yang WS; Yang JH; Hsiao CK; Yang YS; Ho HN
Hum Reprod; 2006 Sep; 21(9):2266-71. PubMed ID: 16757555
[TBL] [Abstract][Full Text] [Related]
12. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
13. Body fat composition and distribution in women with polycystic ovary syndrome.
Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O
Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379
[TBL] [Abstract][Full Text] [Related]
14. Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome.
Leon L; Bacallao K; Gabler F; Romero C; Valladares L; Vega M
Steroids; 2008 Jan; 73(1):88-95. PubMed ID: 17953976
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
16. Obesity reduces the expression of GLUT4 in the endometrium of normoinsulinemic women affected by the polycystic ovary syndrome.
Mozzanega B; Mioni R; Granzotto M; Chiarelli S; Xamin N; Zuliani L; Sicolo N; Marchesoni D; Vettor R
Ann N Y Acad Sci; 2004 Dec; 1034():364-74. PubMed ID: 15731326
[TBL] [Abstract][Full Text] [Related]
17. Premature androgenic alopecia and insulin resistance. Male equivalent of polycystic ovary syndrome?
Starka L; Duskova M; Cermakova I; Vrbiková J; Hill M
Endocr Regul; 2005 Dec; 39(4):127-31. PubMed ID: 16552990
[TBL] [Abstract][Full Text] [Related]
18. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
19. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
20. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women.
Shi Y; Gao X; Sun X; Zhang P; Chen Z
Fertil Steril; 2008 Oct; 90(4):1139-43. PubMed ID: 17889857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
